SELECT PUBLICATIONS

Allegra C, Sargent DJ. Adjuvant therapy for colon cancer — The pace quickens. N Engl J Med 2005;352(26):2746-8. No abstract available

André T et al; Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350(23):2343-51. Abstract

Benatti P et al. Microsatellite instability and colorectal cancer prognosis. Clin Cancer Res 2005;11(23):8332-40. Abstract

Benson AB 3rd et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for Stage II colon cancer. J Clin Oncol 2004;22(16):3408-19. Abstract

Figueredo A et al. Adjuvant therapy for stage II colon cancer: A systematic review from the Cancer Care Ontario Program in evidence-based care’s gastrointestinal cancer disease site group. J Clin Oncol 2004;22(16):3395-407. Abstract

Jen J et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 1994;331(4):213-21. Abstract

Popat S et al. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 2005;23(3):609-18. Abstract

Popat S, Houlston RS. A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis. Eur J Cancer 2005;41(14):2060-70. Abstract

Ribic CM et al. Tumor microsatellite-instability status as a predictor of benefit from f luorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003;349(3):247-57. Abstract

Sarli L et al. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q. Dis Colon Rectum 2004;47(9):1467-82. Abstract

Watanabe T et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 2001;344(16):1196-206. Abstract